top of page

How to Verify a Skin Device Is MFDS-Approved in Korea: Registration Classes, Labels and What to Ask - A Complete Guide

1 day ago
9 min read
A tablet showing a QR code lookup screen, used to check a registration record before a service begins

Verifying a device before treatment is a records check, not a judgement call. Photo: Vizito Visitor Management / Unsplash

Quick answer An MFDS-approved aesthetic device is one that has cleared Korea's premarket review for its class: Class I by notification, Class II by certification or approval, and Classes III and IV by approval [3]. You cannot confirm that status from a brochure. Ask for the device's registered product name and model, check that the machine in the room carries a matching label, and ask whether the planned setting falls inside the approved indication. Approval is a floor, not a ranking.

In this guide

Patients comparing Korean skin clinics are usually given device names long before they are given any regulatory detail. A consultation sheet may list four or five machine names, a package price and a session count, and nothing at all about whether those machines are registered in Korea for the use being proposed. That gap matters, because the approval pathway is the one piece of information in the room that is recorded by a public authority rather than written by the clinic. This guide sets out what the Ministry of Food and Drug Safety (MFDS) approval classes mean, what you can physically verify on the day, and where the evidence on device-related injury actually points.

What MFDS approval actually means

In Korea, medical devices are sorted into four classes, and the premarket route follows the class rather than the marketing claim. MFDS states that Class I devices go through notification, Class II devices through certification or approval, and Class III and Class IV devices through approval [3]. Review is split between bodies: MDITAC handles Class I and Class II certification, while NIFDS, an affiliated agency of MFDS, approves new Class II devices and all Class III and Class IV devices [3]. Separately, manufacturers and importers need a business licence issued by an MFDS regional office, and MFDS notes that an applicant must already hold at least one product licence, so the business licence and the product licence are processed together [3]. The practical consequence is that a lawfully supplied device in a Korean clinic has a registered product name attached to it, and that name is what you should be asking for.

Class

Premarket route

Who reviews it

Class I

Notification

MDITAC (certification function)

Class II

Certification or approval

MDITAC; NIFDS for new Class II devices

Class III

Approval

NIFDS (MFDS affiliated agency)

Class IV

Approval

NIFDS (MFDS affiliated agency)

Premarket routes as described by MFDS. Source: MFDS, Regulations at Four Hierarchical Orders [3].

Why device status changes your risk profile

It is tempting to treat registration as paperwork. The available injury data suggests otherwise, but not in the way most brochures imply. In an analysis of United States liability cases involving cutaneous laser devices between 2012 and 2020, non-physician operators were involved in 49 of 69 cases, or 71 per cent [1]. In a separate analysis of adverse event reports submitted to the United States Food and Drug Administration, radiofrequency devices, diode lasers and intense pulsed light devices were the categories most commonly reported in connection with injuries [2]. Taken together, the signal is that harm clusters around how a device is deployed and by whom, with certain energy categories over-represented. Registration status does not remove that risk; it establishes that a reviewed specification exists against which the clinic's claims can be checked. Separately, it is worth knowing who performs your laser treatment and whether you are being treated in a medical clinic or a beauty salon, since those two facts tend to move the risk more than the machine's brand name does.

A clinic treatment device with a control screen and settings panel

The control panel and the label plate are the two places a device identifies itself. Photo: Sam Moghadam / Unsplash

What you can see in the treatment room

Three things are physically checkable without any special knowledge. First, the label plate: regulated devices carry a manufacturer, a model designation and a serial or lot identifier, usually on the rear or underside of the housing. Second, the on-screen model name, which should match the plate rather than the marketing name used in the consultation. Third, the consumable packaging, since many energy devices only work with a matched tip or cartridge and the packaging carries its own identifiers; our guide to device consumables covers how to ask for that packaging to be opened in front of you. A mismatch between any of the three and the name on your quote is not proof of wrongdoing, but it is a reasonable thing to raise before the first session rather than after it.

Four questions to ask before the first session

  1. What is the registered product name and model of the device you will use on me, as it appears on the label?

  2. Is the treatment you are proposing within that device's approved indication, or is it an off-label use?

  3. Who will operate the device, and what is their licence or qualification?

  4. If a consumable is used, may I see the sealed packaging before it is opened?

These four questions are deliberately specific. A clinic that treats them as routine will usually answer in under a minute, because the answers are things the clinic already has on file. A clinic that treats them as an accusation has told you something useful about how it handles documentation generally. You are not asking for commercial secrets; you are asking for the identity of a regulated object that will be used on your skin.

Approved device, unapproved use

The most common misunderstanding is that approval is a property of the machine alone. It is not: review attaches to a specified device used in a specified way. A device can be lawfully registered in Korea and still be proposed to you for an indication, body area or energy setting that sits outside what was reviewed. Off-label use is a recognised part of medical practice and is not automatically wrong, but it changes what the approval tells you, and it should be disclosed rather than discovered. The same caution applies to stacked protocols: when two or more devices are combined in one visit, the approvals were granted for each device separately, not for the combination. If you are weighing that choice, our guide on how clinics decide between a single device and a combination protocol sets out the questions that matter.

Approval is a floor, not a quality ranking

A registered device is not necessarily the better device for your skin, and an approval number says nothing about operator skill, settings, aftercare or how your skin type will respond. Treat registration as the minimum condition for a conversation, not as evidence that a result is likely. This article is general information and is not medical advice.

Red flags that justify pausing

  • The clinic cannot or will not state the registered product name, only a marketing name.

  • The label plate, the on-screen model and the quote name are three different things, with no explanation.

  • A device is described as newer than the approval system, or imported directly and so not registered yet.

  • The consumable arrives already unsealed, or the clinic declines to show the packaging.

  • Written confirmation of the device and setting is refused, while a deposit is requested the same day.

None of these on its own proves that a device is unregistered. Each of them, though, removes your ability to check, and the reasonable response to losing the ability to check is to delay rather than to proceed. A deposit paid before the device is identified is the hardest thing to reverse later, so the sequencing matters: identify the device, then pay.

What the research says

Litigation data: the operator is the dominant variable

Khalifian and colleagues searched an online national database of public legal documents for cutaneous laser surgery litigation in the United States between 2012 and 2020, and identified 69 liability cases involving a cutaneous laser device. Non-physician operators were involved in 49 cases (71 per cent), non-core physician operators in 12 (17 per cent), plastic surgeons in 6 (9 per cent) and dermatologists in 2 (3 per cent). Laser hair removal was the most litigated procedure at 44 cases (64 per cent), followed by laser skin rejuvenation at 20 cases (30 per cent). Of the 36 cases with a discernible outcome, 19 (53 per cent) were decided in the plaintiff's favour, and the mean indemnity payment was 320,975 US dollars, ranging from 1,665 to 1.5 million US dollars. The authors state the data may underestimate the frequency of injury and litigation caused by unsupervised non-physician operators [1]. Limitation: these are United States legal records, not Korean clinical outcomes, and litigation frequency is not the same as injury frequency. What it means for you: asking who will hold the handpiece is at least as consequential as asking which machine it belongs to.

Device-report data: which categories are most often reported

Tremaine and Avram analysed medical device reports submitted to the United States Food and Drug Administration's MAUDE database, searching in December 2013 for reports covering 1991 through December 2013. The search yielded 1,257 reports, of which 45 were excluded for insufficient data. Reported events included blistering, burns, scarring, dyschromia, fat loss and nerve palsy, and radiofrequency devices, diode lasers and intense pulsed light devices were the categories most commonly reported as related to injuries. The authors conclude that MAUDE is an under-used post-market surveillance resource, while noting that underreporting is a concern [2]. Limitation: a voluntary reporting database cannot give incidence rates, because the number of treatments performed is unknown. What it means for you: if your plan involves radiofrequency, a diode laser or intense pulsed light, the burden of explanation on settings and operator qualification is higher, not lower, than for gentler modalities.

Post-market data of this kind is also something you can look at yourself. The United States FDA publishes public databases covering premarket notifications, premarket approvals, establishment registration and listing, and MAUDE adverse event reports [4]. Korean device records are held separately by MFDS, so a device cleared in one jurisdiction is not thereby registered in the other.

Frequently asked questions

Does an MFDS approval number guarantee the treatment is safe for me?

No. Approval indicates that a device cleared the premarket route for its class [3]. It says nothing about your skin type, your medication history, the settings chosen on the day, or the operator's experience. Safety for you is decided at the consultation, not at the registry.

Can a clinic legally use a device that is not registered in Korea?

Supply and use of medical devices in Korea run through the licensing framework MFDS describes, which ties product licences to licensed manufacturers and importers [3]. If a clinic tells you a device is not yet registered, ask for that in writing before agreeing to anything, and consider deferring.

Is an FDA clearance the same as MFDS approval?

No. They are separate jurisdictions with separate registers. FDA clearance can be checked in FDA's public premarket notification and premarket approval databases [4], but it does not establish Korean registration, and the reverse is also true.

What should I write down during the consultation?

The registered product name and model, the planned setting or energy level if given, the operator's role, the consumable type, and the session count and price. Those five items make any later dispute concrete rather than impressionistic.

Does this apply to injectables as well as energy devices?

Injectables sit under a different regulatory category from energy-based devices, so the specific pathway differs, though the underlying habit is the same: ask for the registered product name rather than the marketing name. Our comparison of lipolysis injection brands shows how widely approval status varies within a single product category.

References

  1. Khalifian S, et al. Causes of Injury and Litigation in Cutaneous Laser Surgery: An Update From 2012 to 2020. Dermatologic Surgery, 2022;48(3):315-319. PMID 35013046.

  2. Tremaine AM, Avram MM. FDA MAUDE data on complications with lasers, light sources, and energy-based devices. Lasers in Surgery and Medicine, 2015;47(2):133-140. DOI 10.1002/lsm.22328.

  3. Ministry of Food and Drug Safety, Republic of Korea. Regulations at Four Hierarchical Orders: medical device classification and premarket review. MFDS, accessed 16 November 2026.

  4. U.S. Food and Drug Administration, Center for Devices and Radiological Health. Medical Device Databases. FDA, content current as of 6 April 2022.

Related reading

About this guide: Korean Plastic Surgery Info is an independent information site. We do not operate, own or represent any clinic, and we take no commission or referral fee from any provider mentioned. Content is compiled from peer-reviewed literature and official regulatory sources, cited above. This article is general information and is not medical advice; decisions about treatment should be made with a licensed clinician who has examined you.

Comments


Exclusively Verified Lowest Price for Korean Plastic Surgery Clinics

(주)팀퍼포먼스 ㅣTeamperformance Co., Ltd.
대표자: 정용훈 ㅣRepresentative Director:  Yonghun Jung
사업자등록번호: 503-87-03152 ㅣBusiness Registration Number: 503-87-03152 

@copyright all reserved teamperformance

bottom of page